BIOCAUSE HEILEN PHARMA
30121110.223.44% ( +0.34 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: BIOCAUSE HEILEN PHARMA(301211) the Revenue is 120.16 M (+5%);the EBIT is 2.83 M (+15.75%);the EPS is 0.02 (+0%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.12B5.00%
----
----
EBIT
0.00B15.75%
----
----
EPS
0.02--
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf